Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ashley Garrill
A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models
Oncology and Therapy
Oncology
Related publications
The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Elderly Patients With Advanced Non-Small Cell Lung Cancer
Current Gerontology and Geriatrics Research
Gerontology
Geriatrics
Estrogen Receptor Β1 Activation Accelerates Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors vs Conventional Chemotherapy in Non–Small Cell Lung Cancer Harboring Wild-Type Epidermal Growth Factor Receptor
JAMA - Journal of the American Medical Association
Medicine
Protein Kinase A-Iα Subunit-Directed Antisense Inhibition of Ovarian Cancer Cell Growth: Crosstalk With Tyrosine Kinase Signaling Pathway
Oncogene
Cancer Research
Genetics
Molecular Biology
Overcoming Resistance to First/Second Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and ALK Inhibitors in Oncogene-Addicted Advanced Non-Small Cell Lung Cancer
Therapeutic Advances in Medical Oncology
Oncology
Association of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment and EGFR Exon 19 Deletion With Frequency of the T790M Mutation in Non-Small Cell Lung Cancer Patients After Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
OncoTargets and Therapy
Oncology
Pharmacology
Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients Aged 80 Years or Older: A Retrospective Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
